In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance

Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)­Os­(N,N′)]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2018-10, Vol.61 (20), p.9246-9255
Hauptverfasser: Coverdale, James P. C, Bridgewater, Hannah E, Song, Ji-Inn, Smith, Nichola A, Barry, Nicolas P. E, Bagley, Ian, Sadler, Peter J, Romero-Canelón, Isolda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9255
container_issue 20
container_start_page 9246
container_title Journal of medicinal chemistry
container_volume 61
creator Coverdale, James P. C
Bridgewater, Hannah E
Song, Ji-Inn
Smith, Nichola A
Barry, Nicolas P. E
Bagley, Ian
Sadler, Peter J
Romero-Canelón, Isolda
description Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)­Os­(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)­Os­(N,N’)­Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.
doi_str_mv 10.1021/acs.jmedchem.8b00958
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6204601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2116847286</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</originalsourceid><addsrcrecordid>eNp9kU9vEzEQxS1ERUPhGyDkYzlsGNv794JURRQiRUqVFK6W1zvbuNq1w9obNf0YfGKcJq3gwmkO83tvRu8R8oHBlAFnn5X20_seG73BflrWAFVWviITlnFI0hLS12QCwHnCcy7OyVvv7wFAMC7ekHMBXEDJiwn5Pbf0p9k5usYOdTA7E_ZU2YYunFadeVTBOEtdS1eoDmuky4f9HVq63qI26Onlarn-ROe2GfUTWu_p0vdm7OmVDUYrq3GgM9dvO3yI-O1GBTozgx77HdpAb7p4wUZ6hd74cMDfkbNWdR7fn-YF-XH99Xb2PVksv81nV4tEpWkVkryAEplIMyig1oUAbNschFaVEDpVoBtV1qJooaoyhrpVTSZaVtR5VpQ51iAuyJej73asDznGdwbVye1gejXspVNG_ruxZiPv3E7mHNIcWDS4PBkM7teIPsjeeI1dpyy60UvOWF6mBS_ziKZHVA_O-wHblzMM5KFOGeuUz3XKU51R9vHvF19Ez_1FAI7Ak9yNg42J_d_zD1mbsrs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2116847286</pqid></control><display><type>article</type><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</creator><creatorcontrib>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</creatorcontrib><description>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)­Os­(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)­Os­(N,N’)­Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.8b00958</identifier><identifier>PMID: 30230827</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Drug Resistance, Neoplasm - drug effects ; Drug Screening Assays, Antitumor ; Humans ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Osmium - chemistry ; Platinum - pharmacology ; Reactive Oxygen Species - metabolism</subject><ispartof>Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9246-9255</ispartof><rights>Copyright © 2018 American Chemical Society 2018 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</citedby><cites>FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</cites><orcidid>0000-0001-9160-1941 ; 0000-0003-3847-4626 ; 0000-0002-7779-6620 ; 0000-0002-0388-6295</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00958$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00958$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30230827$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coverdale, James P. C</creatorcontrib><creatorcontrib>Bridgewater, Hannah E</creatorcontrib><creatorcontrib>Song, Ji-Inn</creatorcontrib><creatorcontrib>Smith, Nichola A</creatorcontrib><creatorcontrib>Barry, Nicolas P. E</creatorcontrib><creatorcontrib>Bagley, Ian</creatorcontrib><creatorcontrib>Sadler, Peter J</creatorcontrib><creatorcontrib>Romero-Canelón, Isolda</creatorcontrib><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)­Os­(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)­Os­(N,N’)­Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Drug Resistance, Neoplasm - drug effects</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Osmium - chemistry</subject><subject>Platinum - pharmacology</subject><subject>Reactive Oxygen Species - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9vEzEQxS1ERUPhGyDkYzlsGNv794JURRQiRUqVFK6W1zvbuNq1w9obNf0YfGKcJq3gwmkO83tvRu8R8oHBlAFnn5X20_seG73BflrWAFVWviITlnFI0hLS12QCwHnCcy7OyVvv7wFAMC7ekHMBXEDJiwn5Pbf0p9k5usYOdTA7E_ZU2YYunFadeVTBOEtdS1eoDmuky4f9HVq63qI26Onlarn-ROe2GfUTWu_p0vdm7OmVDUYrq3GgM9dvO3yI-O1GBTozgx77HdpAb7p4wUZ6hd74cMDfkbNWdR7fn-YF-XH99Xb2PVksv81nV4tEpWkVkryAEplIMyig1oUAbNschFaVEDpVoBtV1qJooaoyhrpVTSZaVtR5VpQ51iAuyJej73asDznGdwbVye1gejXspVNG_ruxZiPv3E7mHNIcWDS4PBkM7teIPsjeeI1dpyy60UvOWF6mBS_ziKZHVA_O-wHblzMM5KFOGeuUz3XKU51R9vHvF19Ez_1FAI7Ak9yNg42J_d_zD1mbsrs</recordid><startdate>20181025</startdate><enddate>20181025</enddate><creator>Coverdale, James P. C</creator><creator>Bridgewater, Hannah E</creator><creator>Song, Ji-Inn</creator><creator>Smith, Nichola A</creator><creator>Barry, Nicolas P. E</creator><creator>Bagley, Ian</creator><creator>Sadler, Peter J</creator><creator>Romero-Canelón, Isolda</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9160-1941</orcidid><orcidid>https://orcid.org/0000-0003-3847-4626</orcidid><orcidid>https://orcid.org/0000-0002-7779-6620</orcidid><orcidid>https://orcid.org/0000-0002-0388-6295</orcidid></search><sort><creationdate>20181025</creationdate><title>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</title><author>Coverdale, James P. C ; Bridgewater, Hannah E ; Song, Ji-Inn ; Smith, Nichola A ; Barry, Nicolas P. E ; Bagley, Ian ; Sadler, Peter J ; Romero-Canelón, Isolda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-6708e1345070bc730eff603ca933c4a0cda8b37f09951ecfad53f17b65786eb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Drug Resistance, Neoplasm - drug effects</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Osmium - chemistry</topic><topic>Platinum - pharmacology</topic><topic>Reactive Oxygen Species - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coverdale, James P. C</creatorcontrib><creatorcontrib>Bridgewater, Hannah E</creatorcontrib><creatorcontrib>Song, Ji-Inn</creatorcontrib><creatorcontrib>Smith, Nichola A</creatorcontrib><creatorcontrib>Barry, Nicolas P. E</creatorcontrib><creatorcontrib>Bagley, Ian</creatorcontrib><creatorcontrib>Sadler, Peter J</creatorcontrib><creatorcontrib>Romero-Canelón, Isolda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coverdale, James P. C</au><au>Bridgewater, Hannah E</au><au>Song, Ji-Inn</au><au>Smith, Nichola A</au><au>Barry, Nicolas P. E</au><au>Bagley, Ian</au><au>Sadler, Peter J</au><au>Romero-Canelón, Isolda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2018-10-25</date><risdate>2018</risdate><volume>61</volume><issue>20</issue><spage>9246</spage><epage>9255</epage><pages>9246-9255</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)­Os­(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)­Os­(N,N’)­Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>30230827</pmid><doi>10.1021/acs.jmedchem.8b00958</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-9160-1941</orcidid><orcidid>https://orcid.org/0000-0003-3847-4626</orcidid><orcidid>https://orcid.org/0000-0002-7779-6620</orcidid><orcidid>https://orcid.org/0000-0002-0388-6295</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2018-10, Vol.61 (20), p.9246-9255
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6204601
source MEDLINE; American Chemical Society Journals
subjects Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Cell Line, Tumor
Cell Proliferation - drug effects
Drug Resistance, Neoplasm - drug effects
Drug Screening Assays, Antitumor
Humans
Organometallic Compounds - chemistry
Organometallic Compounds - pharmacology
Osmium - chemistry
Platinum - pharmacology
Reactive Oxygen Species - metabolism
title In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A15%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Selectivity%20and%20Localization%20of%20Reactive%20Oxygen%20Species%20(ROS)%20Induction%20by%20Osmium%20Anticancer%20Complexes%20That%20Circumvent%20Platinum%20Resistance&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Coverdale,%20James%20P.%20C&rft.date=2018-10-25&rft.volume=61&rft.issue=20&rft.spage=9246&rft.epage=9255&rft.pages=9246-9255&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.8b00958&rft_dat=%3Cproquest_pubme%3E2116847286%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2116847286&rft_id=info:pmid/30230827&rfr_iscdi=true